The postulated causative organism for SARS is a coronavirus that has been identified from respiratory. urine and stool specimens. The mode of transmission appears to be droplet spread; the virus may remain viable outside the body in fomites for up to six hours. Spread of the disease in Hong Kong has been linked to the use of a nebuliser on on infected patient in hospital. poor sewerage systems in a housing estate. and close proximity in the lift areas of a hotel.
Presenting features include chills, rigors and high fevers. plus variably malaise. shortness of breath and diarrhaea1. Contact history should be elicited. Chest x-rays show progressive patchy infiltrates, initially basal but becoming Widespread; pleural effusions are unusual. High resolution a shows characteristic ground gloss appearance and patchy peripheral consolidation. Radiological examples are available online2. Lactate dehydrogenase and creatine kinase are high; white cell and platelet counts are low/normal but often with absolute Iymphopaenia. More details are available on our webslreo. SARS patients must be cohorred, and strict infection control is mandatory at all times. with additional protection for high risk procedures such as intubation. Ideally single room isolation is used but large numbers of cases make this impossible. Stoff education about infection control and adequate provision of equipment is of paramount importance. This advice also holds for all non-SARS patients on the ICU, who ideally should be nursed in positive pressure siderooms with reversed barrier nursing. Only one stoff member at the Prince of Wales ICU has contracted SARS since the current infection control procedures have been strictly enforced. Details of infection control protocols are available on our website3.
Treatment currently involves initial antibiotic treatment to cover standard community ocqulred pneumonia. titrated oxygen, ribavirin and steroids (1 mglkglday prednisolone or equivalent). If there is deteriorarion of oxygenation or ongoing swinging fever pulsed methylprednisolone is given with brood-spectrum antibiotic cover. provided there is no evidence of superimposed infection. These therapies appear useful in controlling the disease. Additional therapies include convalescent serum from recovering patients. plasmapheresis and use of intravenous standard or IgM-enriched immunoglobulin. As yet there is no controlled evidence as to whether any of these agents alter the disease course.
Approxirnorely 20-25% of SARS cases require ICU admission for respiratory failure.
Most SARS patients have single organ failure and respiratory management and surveillance for secondary infection are the focus of treatment. Oxygen therapy via nasal cannulae and simple face masks is preferable to venturi masks as these are likely to generate greater local air turbulence. Non-invasive ventilation must not be used in SARS cases as it is impossible to scavenge expired gas. Invasive ventilation is required in 50-60% of ICU cases and is problematic, with characteristically stiff lungs. poor response to PEEP or recruitment manoeuvres and only a variable response to prone positioning. A low volume protective ventilation strategy is prudent. The incidence of barotrauma is high. occurring or "safe" ventilarory pressures. and even spontaneously in non-ventilated patients.
The disease course for ICU SARS patients is protracted. and long term ventilation is required. The necessary heavy sedation and paralysis complicate the weaning process. Superimposed infection is a major concern.
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and the usual morkers of infection are difficult to interpret due to effect of steroids and underlying SARS disease. Development of multiple organ dysfunction suggesrs additional sepsis. Anti-infective agents are necessarily brood spectrum and include anti-fungal, anti-MRSA and anti-Gram negative agents, being narrowed if microbiologicol cultures are positive.
Large numbers of SARS cases can overwhelm ICU bed copoclry and medical and nursing steff must be seconded from other areas to help run additional beds. Sufficient, albeit rapid training, will help to minimise their onxiery and improve their performance in the unfamiliar environment of ICU. A number of tutorials for novice ICU doctors are available for download from our websiteJ.
Outcomes for SARS are subject to change, as the disease has still not reached a stable point. Current figures for Hong Kong (on JOth April 200J) show that there have been 150 deaths from 1572 cases with 759 recoveries4. The rnojonry of deaths are in elderly patients (over 60 years) and patients with co-rnorbidiry although recently younger healthy patients have succumbed which has raised the suspicion of increased virulence due to viral mutation. It is too eorly to give ICU or hospital mortaliry figures for ICU cases as many are still undergoing treatment. So far it is estimated that hospital rnorrohry at the Prince of Wales Hospital will be around 50% for ventilated coses. Many SARS cases are health care workers (22% in Hong Kong) and rhis odds greatly to the stress experienced by stoff when treating SARS patients. Concerns about infecting family members are high and quidelines for measures to adopt at home are available on the CDC website5. Adequate information and psychological and logistic support are essential.
The diagnosis of SARS remains principally a clinical one; so far rapid antigen tests are not specific, and virus isolation not guaranteed. The search is on for effective anti-viral agents, either singly or in combination, and for a vaccine, although the latter may roke many months to years. In the meanwhile the treatment for SARS is a work in progress. For regularly updated information on epidemiology and clinical issues the websites listed below are useful.
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